Four Cases of Kawasaki Syndrome Complicated With Myocarditis
Background Myocarditis frequently occurs in the acute phase of Kawasaki syndrome (KS), and a few severe cases have been reported. Four cases of myocarditis in KS required additional catecholamine treatment because of severe left ventricular dysfunction (LVD). Case reports Three cases were relatively...
Gespeichert in:
Veröffentlicht in: | Circulation Journal 2006, Vol.70(2), pp.202-205 |
---|---|
Hauptverfasser: | , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 205 |
---|---|
container_issue | 2 |
container_start_page | 202 |
container_title | Circulation Journal |
container_volume | 70 |
creator | Yoshikawa, Hideki Nomura, Yuichi Masuda, Kiminori Hazeki, Daisuke Yotsumoto, Keiko Arata, Michiko Kamenosono, Akira Yanagi, Sadamitsu Yoshinaga, Masao Kawano, Yoshifumi |
description | Background Myocarditis frequently occurs in the acute phase of Kawasaki syndrome (KS), and a few severe cases have been reported. Four cases of myocarditis in KS required additional catecholamine treatment because of severe left ventricular dysfunction (LVD). Case reports Three cases were relatively older children and 2 cases were complicated with encephalopathy. All 4 developed coronary artery abnormalities during convalescence. There was 1 case of LVD because of prolonged severe inflammation prior to administration of intravenous immunoglobulin (IVIG). The remaining 3 patients had normal values for ejection fraction before the administration of IVIG but decreased values (42-51%) and increased C-reactive protein levels after IVIG administration. These cases demonstrate an association between myocarditis in KS and severe or worsened inflammation. Conclusions Even with prior normal echocardiography, careful observation of cardiac function may be necessary for patients with KS, especially older children, when inflammation deteriorates after administration of IVIG. (Circ J 2006; 70: 202 - 205) |
doi_str_mv | 10.1253/circj.70.202 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70731796</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>70731796</sourcerecordid><originalsourceid>FETCH-LOGICAL-c475t-5e9506e9ce955c2ae0fca7a7ef663b491321dc77ab64a8c5b0976e28a8e0854a3</originalsourceid><addsrcrecordid>eNpNkDFPwzAQRi0EoqWwMaNMTKTYsWPHEksVUUAUMQBijK7OhbokTbETof57QlNRlvtOundv-Ag5Z3TMophfG-vMcqzoOKLRARkyLlQokogebncZ6kTwATnxfklppGmsj8mAScFFwuSQ3Ezr1gUpePRBXQSP8A0ePm3wslnlrq4wSOtqXVoDDebBu20WwdOmNuBy21h_So4KKD2e7XJE3qa3r-l9OHu-e0gns9AIFTdhjDqmErXpMjYRIC0MKFBYSMnnQjMesdwoBXMpIDHxnGolMUogQZrEAviIXPbetau_WvRNVllvsCxhhXXrM0UVZ0rLDrzqQeNq7x0W2drZCtwmYzT7bSvbttU9ZF1bHX6x87bzCvM9vKunAyY9sPQNfOAfAK6xpsR_tn500v1tAS7DFf8BY7N9aQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>70731796</pqid></control><display><type>article</type><title>Four Cases of Kawasaki Syndrome Complicated With Myocarditis</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>J-STAGE (Japan Science & Technology Information Aggregator, Electronic) Freely Available Titles - Japanese</source><creator>Yoshikawa, Hideki ; Nomura, Yuichi ; Masuda, Kiminori ; Hazeki, Daisuke ; Yotsumoto, Keiko ; Arata, Michiko ; Kamenosono, Akira ; Yanagi, Sadamitsu ; Yoshinaga, Masao ; Kawano, Yoshifumi</creator><creatorcontrib>Yoshikawa, Hideki ; Nomura, Yuichi ; Masuda, Kiminori ; Hazeki, Daisuke ; Yotsumoto, Keiko ; Arata, Michiko ; Kamenosono, Akira ; Yanagi, Sadamitsu ; Yoshinaga, Masao ; Kawano, Yoshifumi</creatorcontrib><description>Background Myocarditis frequently occurs in the acute phase of Kawasaki syndrome (KS), and a few severe cases have been reported. Four cases of myocarditis in KS required additional catecholamine treatment because of severe left ventricular dysfunction (LVD). Case reports Three cases were relatively older children and 2 cases were complicated with encephalopathy. All 4 developed coronary artery abnormalities during convalescence. There was 1 case of LVD because of prolonged severe inflammation prior to administration of intravenous immunoglobulin (IVIG). The remaining 3 patients had normal values for ejection fraction before the administration of IVIG but decreased values (42-51%) and increased C-reactive protein levels after IVIG administration. These cases demonstrate an association between myocarditis in KS and severe or worsened inflammation. Conclusions Even with prior normal echocardiography, careful observation of cardiac function may be necessary for patients with KS, especially older children, when inflammation deteriorates after administration of IVIG. (Circ J 2006; 70: 202 - 205)</description><identifier>ISSN: 1346-9843</identifier><identifier>EISSN: 1347-4820</identifier><identifier>DOI: 10.1253/circj.70.202</identifier><identifier>PMID: 16434816</identifier><language>eng</language><publisher>Japan: The Japanese Circulation Society</publisher><subject>Catecholamines - therapeutic use ; Child ; Child, Preschool ; Coronary Vessel Anomalies - drug therapy ; Coronary Vessel Anomalies - etiology ; Echocardiography ; Encephalopathy ; Female ; Humans ; Immunoglobulins, Intravenous - administration & dosage ; Kawasaki syndrome ; Male ; Mucocutaneous Lymph Node Syndrome - complications ; Mucocutaneous Lymph Node Syndrome - drug therapy ; Myocarditis ; Myocarditis - complications ; Myocarditis - drug therapy ; Ventricular Dysfunction, Left - complications ; Ventricular Dysfunction, Left - drug therapy</subject><ispartof>Circulation Journal, 2006, Vol.70(2), pp.202-205</ispartof><rights>2006 THE JAPANESE CIRCULATION SOCIETY</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c475t-5e9506e9ce955c2ae0fca7a7ef663b491321dc77ab64a8c5b0976e28a8e0854a3</citedby><cites>FETCH-LOGICAL-c475t-5e9506e9ce955c2ae0fca7a7ef663b491321dc77ab64a8c5b0976e28a8e0854a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,1883,4024,27923,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16434816$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yoshikawa, Hideki</creatorcontrib><creatorcontrib>Nomura, Yuichi</creatorcontrib><creatorcontrib>Masuda, Kiminori</creatorcontrib><creatorcontrib>Hazeki, Daisuke</creatorcontrib><creatorcontrib>Yotsumoto, Keiko</creatorcontrib><creatorcontrib>Arata, Michiko</creatorcontrib><creatorcontrib>Kamenosono, Akira</creatorcontrib><creatorcontrib>Yanagi, Sadamitsu</creatorcontrib><creatorcontrib>Yoshinaga, Masao</creatorcontrib><creatorcontrib>Kawano, Yoshifumi</creatorcontrib><title>Four Cases of Kawasaki Syndrome Complicated With Myocarditis</title><title>Circulation Journal</title><addtitle>Circ J</addtitle><description>Background Myocarditis frequently occurs in the acute phase of Kawasaki syndrome (KS), and a few severe cases have been reported. Four cases of myocarditis in KS required additional catecholamine treatment because of severe left ventricular dysfunction (LVD). Case reports Three cases were relatively older children and 2 cases were complicated with encephalopathy. All 4 developed coronary artery abnormalities during convalescence. There was 1 case of LVD because of prolonged severe inflammation prior to administration of intravenous immunoglobulin (IVIG). The remaining 3 patients had normal values for ejection fraction before the administration of IVIG but decreased values (42-51%) and increased C-reactive protein levels after IVIG administration. These cases demonstrate an association between myocarditis in KS and severe or worsened inflammation. Conclusions Even with prior normal echocardiography, careful observation of cardiac function may be necessary for patients with KS, especially older children, when inflammation deteriorates after administration of IVIG. (Circ J 2006; 70: 202 - 205)</description><subject>Catecholamines - therapeutic use</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>Coronary Vessel Anomalies - drug therapy</subject><subject>Coronary Vessel Anomalies - etiology</subject><subject>Echocardiography</subject><subject>Encephalopathy</subject><subject>Female</subject><subject>Humans</subject><subject>Immunoglobulins, Intravenous - administration & dosage</subject><subject>Kawasaki syndrome</subject><subject>Male</subject><subject>Mucocutaneous Lymph Node Syndrome - complications</subject><subject>Mucocutaneous Lymph Node Syndrome - drug therapy</subject><subject>Myocarditis</subject><subject>Myocarditis - complications</subject><subject>Myocarditis - drug therapy</subject><subject>Ventricular Dysfunction, Left - complications</subject><subject>Ventricular Dysfunction, Left - drug therapy</subject><issn>1346-9843</issn><issn>1347-4820</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpNkDFPwzAQRi0EoqWwMaNMTKTYsWPHEksVUUAUMQBijK7OhbokTbETof57QlNRlvtOundv-Ag5Z3TMophfG-vMcqzoOKLRARkyLlQokogebncZ6kTwATnxfklppGmsj8mAScFFwuSQ3Ezr1gUpePRBXQSP8A0ePm3wslnlrq4wSOtqXVoDDebBu20WwdOmNuBy21h_So4KKD2e7XJE3qa3r-l9OHu-e0gns9AIFTdhjDqmErXpMjYRIC0MKFBYSMnnQjMesdwoBXMpIDHxnGolMUogQZrEAviIXPbetau_WvRNVllvsCxhhXXrM0UVZ0rLDrzqQeNq7x0W2drZCtwmYzT7bSvbttU9ZF1bHX6x87bzCvM9vKunAyY9sPQNfOAfAK6xpsR_tn500v1tAS7DFf8BY7N9aQ</recordid><startdate>2006</startdate><enddate>2006</enddate><creator>Yoshikawa, Hideki</creator><creator>Nomura, Yuichi</creator><creator>Masuda, Kiminori</creator><creator>Hazeki, Daisuke</creator><creator>Yotsumoto, Keiko</creator><creator>Arata, Michiko</creator><creator>Kamenosono, Akira</creator><creator>Yanagi, Sadamitsu</creator><creator>Yoshinaga, Masao</creator><creator>Kawano, Yoshifumi</creator><general>The Japanese Circulation Society</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>2006</creationdate><title>Four Cases of Kawasaki Syndrome Complicated With Myocarditis</title><author>Yoshikawa, Hideki ; Nomura, Yuichi ; Masuda, Kiminori ; Hazeki, Daisuke ; Yotsumoto, Keiko ; Arata, Michiko ; Kamenosono, Akira ; Yanagi, Sadamitsu ; Yoshinaga, Masao ; Kawano, Yoshifumi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c475t-5e9506e9ce955c2ae0fca7a7ef663b491321dc77ab64a8c5b0976e28a8e0854a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Catecholamines - therapeutic use</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>Coronary Vessel Anomalies - drug therapy</topic><topic>Coronary Vessel Anomalies - etiology</topic><topic>Echocardiography</topic><topic>Encephalopathy</topic><topic>Female</topic><topic>Humans</topic><topic>Immunoglobulins, Intravenous - administration & dosage</topic><topic>Kawasaki syndrome</topic><topic>Male</topic><topic>Mucocutaneous Lymph Node Syndrome - complications</topic><topic>Mucocutaneous Lymph Node Syndrome - drug therapy</topic><topic>Myocarditis</topic><topic>Myocarditis - complications</topic><topic>Myocarditis - drug therapy</topic><topic>Ventricular Dysfunction, Left - complications</topic><topic>Ventricular Dysfunction, Left - drug therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yoshikawa, Hideki</creatorcontrib><creatorcontrib>Nomura, Yuichi</creatorcontrib><creatorcontrib>Masuda, Kiminori</creatorcontrib><creatorcontrib>Hazeki, Daisuke</creatorcontrib><creatorcontrib>Yotsumoto, Keiko</creatorcontrib><creatorcontrib>Arata, Michiko</creatorcontrib><creatorcontrib>Kamenosono, Akira</creatorcontrib><creatorcontrib>Yanagi, Sadamitsu</creatorcontrib><creatorcontrib>Yoshinaga, Masao</creatorcontrib><creatorcontrib>Kawano, Yoshifumi</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Circulation Journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yoshikawa, Hideki</au><au>Nomura, Yuichi</au><au>Masuda, Kiminori</au><au>Hazeki, Daisuke</au><au>Yotsumoto, Keiko</au><au>Arata, Michiko</au><au>Kamenosono, Akira</au><au>Yanagi, Sadamitsu</au><au>Yoshinaga, Masao</au><au>Kawano, Yoshifumi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Four Cases of Kawasaki Syndrome Complicated With Myocarditis</atitle><jtitle>Circulation Journal</jtitle><addtitle>Circ J</addtitle><date>2006</date><risdate>2006</risdate><volume>70</volume><issue>2</issue><spage>202</spage><epage>205</epage><pages>202-205</pages><issn>1346-9843</issn><eissn>1347-4820</eissn><abstract>Background Myocarditis frequently occurs in the acute phase of Kawasaki syndrome (KS), and a few severe cases have been reported. Four cases of myocarditis in KS required additional catecholamine treatment because of severe left ventricular dysfunction (LVD). Case reports Three cases were relatively older children and 2 cases were complicated with encephalopathy. All 4 developed coronary artery abnormalities during convalescence. There was 1 case of LVD because of prolonged severe inflammation prior to administration of intravenous immunoglobulin (IVIG). The remaining 3 patients had normal values for ejection fraction before the administration of IVIG but decreased values (42-51%) and increased C-reactive protein levels after IVIG administration. These cases demonstrate an association between myocarditis in KS and severe or worsened inflammation. Conclusions Even with prior normal echocardiography, careful observation of cardiac function may be necessary for patients with KS, especially older children, when inflammation deteriorates after administration of IVIG. (Circ J 2006; 70: 202 - 205)</abstract><cop>Japan</cop><pub>The Japanese Circulation Society</pub><pmid>16434816</pmid><doi>10.1253/circj.70.202</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1346-9843 |
ispartof | Circulation Journal, 2006, Vol.70(2), pp.202-205 |
issn | 1346-9843 1347-4820 |
language | eng |
recordid | cdi_proquest_miscellaneous_70731796 |
source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; J-STAGE (Japan Science & Technology Information Aggregator, Electronic) Freely Available Titles - Japanese |
subjects | Catecholamines - therapeutic use Child Child, Preschool Coronary Vessel Anomalies - drug therapy Coronary Vessel Anomalies - etiology Echocardiography Encephalopathy Female Humans Immunoglobulins, Intravenous - administration & dosage Kawasaki syndrome Male Mucocutaneous Lymph Node Syndrome - complications Mucocutaneous Lymph Node Syndrome - drug therapy Myocarditis Myocarditis - complications Myocarditis - drug therapy Ventricular Dysfunction, Left - complications Ventricular Dysfunction, Left - drug therapy |
title | Four Cases of Kawasaki Syndrome Complicated With Myocarditis |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T18%3A19%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Four%20Cases%20of%20Kawasaki%20Syndrome%20Complicated%20With%20Myocarditis&rft.jtitle=Circulation%20Journal&rft.au=Yoshikawa,%20Hideki&rft.date=2006&rft.volume=70&rft.issue=2&rft.spage=202&rft.epage=205&rft.pages=202-205&rft.issn=1346-9843&rft.eissn=1347-4820&rft_id=info:doi/10.1253/circj.70.202&rft_dat=%3Cproquest_cross%3E70731796%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=70731796&rft_id=info:pmid/16434816&rfr_iscdi=true |